A phase I pharmacokinetic and translational study of the novel vascular targeting agent combretastatin a-4 phosphate on a single-dose intravenous schedule in patients with advanced cancer. (Q44030346)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase I pharmacokinetic and translational study of the novel vascular targeting agent combretastatin a-4 phosphate on a single-dose intravenous schedule in patients with advanced cancer. |
scientific article |
Statements
A phase I pharmacokinetic and translational study of the novel vascular targeting agent combretastatin a-4 phosphate on a single-dose intravenous schedule in patients with advanced cancer (English)
Afshin Dowlati
Kelly Robertson
Matthew Cooney
William P Petros
Michael Stratford
John Jesberger
Niusha Rafie
Beth Overmoyer
Vinit Makkar
Bruce Stambler
Anne Taylor
John Waas
Jonathan S Lewin
Keith R McCrae